VEGFA and metabolic dysfunction-associated steatotic liver disease: In addition, compared with age-matched FVB mice, K14-VEGF-A-transgenic mice exhibited increased hepatomegaly and liver weight with age increasing (Figure 1G), simultaneously accompanying with the presence of features non-alcoholic fatty liver disease (NAFLD), including liver cell hypertrophy and accumulation of lipid droplets in the liver (Figures 1H–K).